Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis.
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).
Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1.
Deubiquitinating Enzymes
Across the universe of K-RAS mutations in non-small-cell-lung cancer.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Across the universe of K-RAS mutations in non-small-cell-lung cancer.
Across the universe of K-RAS mutations in non-small-cell-lung cancer. Curr Pharm Des. 2014; 20(24):3933-43.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
Humans
Lung Neoplasms
Mutation
ras Proteins
authors with profiles
Marina Chiara Garassino